Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: Graft and recipient characteristics in two cases of insulin- independence under maintenance immunosuppression for prior kidney graft

Diabetologia

Volumn 41, Issue 4, 1998, Pages 452-459

  Keymeulen, B ^a   Ling, Z ^a   Gorus, F K ^a   Delvaux, G ^a   Bouwens, L ^a   Grupping, A ^a   Hendrieckx, C ^a   Pipeleers Marichal, M ^a   Van Schravendijk, C ^a   Salmela, K ^b   Pipeleers, D G ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoantibodies; Beta cells; Diabetes mellitus; Islets; Transplantation

Indexed keywords

AUTOANTIBODY;

ADULT; ARTICLE; BODY WEIGHT; CELL VIABILITY; CLINICAL ARTICLE; DIET RESTRICTION; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MALE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; QUALITY CONTROL;

ADOLESCENT; ADULT; AUTOANTIBODIES; BLOOD GLUCOSE; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GLUCAGON; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HISTOCOMPATIBILITY TESTING; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER; MALE; MIDDLE AGED; TISSUE DONORS; TRANSPLANTATION, HETEROTOPIC;

EID: 6844239526     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050929     Document Type: Article

References (39)

1. Scharp DW, Lacy PE, Santiago JV et al. (1991) Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 51: 76-85
2. Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV (1992) Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin- dependent) diabetes mellitus. Diabetologia 35: 89-95
3. Ricordi C, Tzakis AG, Carroll PB, Zeng Y et al. (1992) Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 53: 407-414
4. Gores PF, Najarian JS, Stephanian E, Lloveras JJ, Kelley SL, Sutherland DE (1993) Insulin independence in type 1 diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 341: 19-21
5. Soon-Shiong P, Heintz RE, Merideth N et al. (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343: 950-951
6. Hering BJ, Browatzki CC, Schultz A, Bretzel RG, Federlin KF (1993) Clinical islet transplantation - registry report, accomplishments in the past and future needs. Cell Transplantation 2: 269-282
7. Secchi A, Socci C, Maffi P, Taglietti MV et al. (1997) Islet transplantation in IDDM patients. Diabetologia 40: 225-231
8. Hering BJ, Brendel MD, Schultz AO, Schultz B, Bretzel RG (1996) International Islet Transplant Registry Newsletter 56: 1-19
9. Sutherland DER, Gores PF, Hering BJ, Wahoff D, McKeehen DA, Gruessner RW (1996) Islet transplantation: an update. Diab Met Rev 12: 137-150
10. Lacy PE (1993) Status of islet cell transplantation. Diabetes Rev 1: 76-92
11. Pipeleers D, Keymeulen B, Korbutt G (1994) Islet transplantation. In: Marshall S, Home P (eds) Diabetes Annual 8. Elsevier Science Publishers, Amsterdam, pp 299-330
12. Pipeleers D (1994) Treatment of diabetes by islet cell transplantation. In: Baya C (ed) Biomedical and health research, vol 3. Advances in medical biology. IOS Press, Amsterdam, pp 185-197
13. 65- autoantibodies in new-onset IDDM patients and help predict the disease in their siblings. Diabetologia 40: 95-99
14. Vandewalle CL, Decraene T, Schuit FC et al. (1993) Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes before age 10 years but not at onset between age 10-40 years. Diabetologia 36: 1155-1162
15. Leonhardt U, Tytko A, Exner B et al. (1993) The effect of different solutions for organ preservation on immediate postischemic pancreatic function in vitro. Transplantation 55: 11-14
16. Warnock GL, Ellis D, Rajotte RV, Dawidson I, Baekkeskov S, Egebjerg J (1988) Studies of the isolation and viability of human islets of Langerhans. Transplantation 45: 957-963
17. Ling Z, Pipeleers D (1996) Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 98: 2805-2812
18. Rajotte RV, Warnock GL, Goulombe MG (1988) Islet cryopreservation: methods and experimental results in rodents, large mammals and humans. In: Van Schilfgaarde R, Hardy MA (eds) Transplantation of the endocrine pancreas in diabetes mellitus. Elsevier Science Publishers, Amsterdam, London, New-York, Tokyo, pp 125-135
19. Bouwens L, Lu WG, De Krijger R (1997) Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 40: 398-404
20. Lu WG, Pipeleers DG, Klöppel G, Bouwens L (1996) Comparative immunocytochemical study of MHC class II expression in human donor pancreas and isolated islets. Virchows Arch 429: 205-211
21. Keymeulen B, Korbutt G, De Paepe M, Klöppel G, Pipeleers DG (1996) Long-term metabolic control by rat islet grafts depends on the composition of the implant. Diabetes 45: 1814-1821
22. Pipeleers DG, Pipeleers-Marichal M, Hannaert JC et al. (1991) Transplantation of purified islet cells in diabetic rats. I Standardization of islet cell grafts. Diabetes 40: 908-919
23. Ricordi C, Gray DW, Hering B et al. (1990) Islet isolation assessment in man and large animals. Acta Diabetol Lat 27: 185-195
24. Stenman UH, Pesonen K, Ylinen K, Huhtala ML, Teramo K (1984) Rapid Chromatographic quantitation of glycosylated haemoglobins. J Chromatograph 297: 327-332
25. Bingley PJ, Colman P, Eisenbarth GS et al. (1992) Standardization of IVGTT to predict IDDM. Diabetes Care 15: 1313-1316
26. Lacy PE, Davie JM, Finke EH (1979) Prolongation of islet allograft survival following in vitro culture (24°C) and a single injection of ALS. Science 204: 312-313
27. Faustman D, Hauptfeld V, Lacy P, Davie J (1981) Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci USA 78: 5156-5159
28. Markmann JF, Tomaszewski J, Posselt AM et al. (1990) The effect of islet cell culture in vitro at 24°C on graft survival and MHC antigen expression. Transplantation 49: 272-277
29. Pipeleers DG, Pipeleers-Marichal M, Vanbrabandt B, Duys S (1991) Transplantation of purified islet cells in diabetic rats. II Immunogenicity of allografted islet beta cells. Diabetes 40: 920-930
30. Pavlovic D, Van De Winkel M, Van der Auwera B et al. (1997) Effect of interferon-γ and glucose on MHC class I and class II expression by pancreatic β and non-β-cells. J Clin Endocrinol Metab 82: 2329-2336
31. Jaeger C, Hering BJ, Dyrberg T, Federlin K, Bretzel RG (1996) Islet cell antibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after-kidney transplantation. Transplantation 62: 424-426
32. Kaufman DL, Clare-Salzer M, Tian J et al. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72
33. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice, Nature 366: 72-75
34. Luzi L, Hering BJ, Socci C et al. (1996) Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 97: 2611-2618
35. DeFronzo RA, Hendler R, Simonson D (1982) Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31: 795-801
36. Bouwens L, Wang RN, De Blay E, Pipeleers DG, Klöppel G (1994) Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas. Diabetes 43: 1279-1283
37. Pavlovic D, Van De Winkel M, Van der Auwera B, Chen MC, Schuit F, Bouwens L, Pipeleers D (1997) Effect of interferon-γ and glucose on MHC class I and class II expression by pancreatic β and non-β cells. J Clin Endocr Metab 82: 2329-2336
38. Creutzfeldt W, Ebert R (1985) New developments in the incretin concept. Diabetologia 28: 565-576
39. Pipeleers D (1987) The biosociology of pancreatic B cells. Diabetologia 30: 277-291